Multi-domain interventions for the prevention of dementia and cognitive decline.

  title={Multi-domain interventions for the prevention of dementia and cognitive decline.},
  author={Melanie Hafdi and Marieke Peternella Hoevenaar-Blom and Edo Richard},
  journal={The Cochrane database of systematic reviews},
BACKGROUND Dementia is a worldwide concern. Its global prevalence is increasing. Currently, no effective medical treatment exists to cure or to delay the onset of cognitive decline or dementia. Up to 40% of dementia is attributable to potentially modifiable risk factors, which has led to the notion that targeting these risk factors might reduce the incidence of cognitive decline and dementia. Since sporadic dementia is a multifactorial condition, thought to derive from multiple causes and risk… 
1 Citations

Embodied Prevention

Evidence-based recommendations for lifestyles to promote healthy cognitive aging (exercise, education, non-smoking, balanced diet, etc.) root in reductionistic studies of mostly physical measurable



Multidomain Interventions to Prevent Cognitive Impairment, Alzheimer’s Disease, and Dementia: From FINGER to World-Wide FINGERS

The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) is the first large, long-term RCT to demonstrate that a multidomain lifestyle-based intervention ameliorating vascular and lifestyle-related risk factors can preserve cognitive functioning and reduce the risk of cognitive decline among older adults at increased risk of dementia.

Physical Activity Interventions in Preventing Cognitive Decline and Alzheimer-Type Dementia

This systematic review reports a synthesis of the evidence assessing the effectiveness of physical activity interventions in slowing cognitive decline and delaying the onset of cognitive impairment and dementia in adults without diagnosed cognitive impairments.

A Population Perspective on Prevention of Dementia

An overview of available evidence for the potential for dementia prevention is given and methodological issues that might complicate the development of effective prevention interventions are discussed, to explore the opportunities and challenges for future dementia prevention research.

Statins for the prevention of dementia.

Good evidence that statins given in late life to people at risk of vascular disease do not prevent cognitive decline or dementia is found and it seems feasible that statin could prevent dementia due to their role in cholesterol reduction.

Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia.

No convincing evidence from the trials identified that blood pressure lowering in late-life prevents the development of dementia or cognitive impairment in hypertensive patients with no apparent prior cerebrovascular disease is identified.

Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia.

This updated systematic review investigated the effect on cognitive function of the type of treatment and level of metabolic control in people with Type 2 diabetes and found that the intensity of glycaemic control may have little or no effect on all-cause mortality.

Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment

The hypothesis that depression is a risk factor for dementia and preventing the recurrence of depression in older adults may prevent or delay the onset of dementia is supported.

Multidomain Lifestyle Intervention Strategies for the Delay of Cognitive Impairment in Healthy Aging

The results of the identified original studies reveal that multidomain lifestyle interventions generate significant effects and there is a call for the implementation of effective lifestyle prevention programs, which would involve goal-setting and would focus on the prevention of crucial risk factors threatening the target group of elderly people.

Dementia prevention: methodological explanations for inconsistent results.

The aim of this paper is to review the epidemiologic data linking potential protective factors to dementia or cognitive decline and to discuss the methodological limitations that could explain conflicting results.